RESEARCH PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Difficult-to-control blood pressure can be attributed to a mismatch between the haemodynamic type of hypertension and the drug class used in treatment. Impedance cardiography may be a useful tool for enabling the individualization of antihypertensive therapy. The aim was to investigate the distribution of haemodynamic types of HT among hypertensive patients in an outpatient clinic.

Material and methods:
This was a prospective, observational study of patients with primary hypertension at an outpatient clinic. A 10-minute ICG examination was performed in 189 consecutive, patients (118 men and 71 women). Patients were divided into groups based on whether their hypertension was well-controlled (140/90 mmHg, n=95). They were also stratified according to haemodynamic states.

Results:
Patients with poorly controlled blood pressure compared to patients with well controlled blood pressure had a high haemodynamic output in 6.3% vs. 2.1% (p=0.153), and high vascular resistance in 41.1% vs. 27.7% (p=0.037), and balanced haemodynamic states in 52.6% vs. 70.2% (0 80 beats/min) and fluid retention (p<0.01).

Conclusions:
Half of the examined patients did not achieve the therapeutic goals for hypertension treatment. Differences in haemodynamic state of well and poor controlled hypertension groups suggests the usefulness of impedance cardiography-targeted hypertension treatment.

ACKNOWLEDGEMENTS
This study was supported by funds from the Polish National Centre (Decision No. DEC-2012/07/B/NZ5/00017 and ST-72), which had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 
REFERENCES (26)
1.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16(4): 223–237. doi: 10.1038/s41581-019-0244-2.
 
2.
Trzeciak BG, Siebert J, Gutknecht P, Molisz A, Filipiak KJ, Wozakowska-KapŁon B. Cardiovascular risk factors determined via the internet in 2 periods of time: 2004–2009 and 2010–2015 in Poland. Int J Occup Med Environ Health. 2017; 30(3). doi: 10.13075/ijomeh.1896.00835.
 
3.
Trzeciak B, Gutknecht P, Molisz A, Siebert J. Fatal cardiovascular risk in Poland as determined via internet. Ann Agric Environ Med. 2017; 24(2). doi:10.5604/12321966.1235161.
 
4.
Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002; (328): 1–32. Accessed January 16, 2017. http://www.ncbi.nlm.nih.gov/pu....
 
5.
Niklas A, Flotyńska A, Puch-Walczak A, et al. Prevalence, awareness, treatment and control of hypertension in the adult Polish population – Multi-center National Population Health Examination Surveys – WOBASZ studies. Arch Med Sci. Published online 2018. doi: 10.5114/aoms.2017.72423.
 
6.
Using the Internet to Determine Fatal Cardiovascular Risk in the Polish Population. Forum Med Rodz. 2011; 5(3): 187–200. Accessed June 3, 2015. http://czasopisma.viamedica.pl....
 
7.
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104. doi:10.1093/eurheartj/ehy339.
 
8.
Hiremath S, Sapir-Pichhadze R, Nakhla M, et al. Hypertension Canada’s 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension. Can J Cardiol. 2020; 36(5): 625–634. doi: 10.1016/j.cjca.2020.02.083.
 
9.
Li R, Liang N, Bu F, Hesketh T. The effectiveness of self-management of hypertension in adults using mobile health: Systematic review and meta-analysis. JMIR mHealth uHealth. 2020; 8(3). doi: 10.2196/17776.
 
10.
Treciokiene I, Postma M, Nguyen T, et al. Healthcare professional-led interventions on lifestyle modifications for hypertensive patients – a systematic review and meta-analysis. BMC Fam Pract. 2021; 22(1): 63. doi: 10.1186/s12875-021-01421-z.
 
11.
Prosser HCG, Azzam O, Schlaich MP. Resistant Hypertension: Which Agent? Heart Lung Circ. 2018; 27(8): 911–916. doi: 10.1016/j.hlc.2018.02.013.
 
12.
Aoka Y, Hagiwara N, Kasanuki H. Heterogeneity of Hemodynamic Parameters in Untreated Primary Hypertension, and Individualization of Antihypertensive Therapy Based on Noninvasive Hemodynamic Measurements. Clin Exp Hypertens. 2013; 35(1): 61–66. doi: 10.3109/10641963.2012.690469.
 
13.
Khraim F, Pike R. Impedance Cardiography-Guided Treatment of Hypertension: A Review of the Literature. Can J Cardiovasc Nurs. Published online 2014.
 
14.
Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med. 2020; 30(3): 160–164. doi: 10.1016/j.tcm.2019.05.003.
 
15.
Medina-Lezama J, Narvaez-Guerra O, Herrera-Enriquez K, et al. Hemodynamic patterns identified by impedance cardiography predict mortality in the general population: The PREVENCION study. J Am Heart Assoc. 2018; 7(18). doi: 10.1161/JAHA.118.009259.
 
16.
Rada MA, Cuffaro PE, Galarza CR, et al. Predictive value of non-invasive hemodynamic measurement by means of impedance cardiography in hypertensive subjects older than 50 years of age. Clin Exp Hypertens. 2014; 36(5): 280–284. doi: 10.3109/10641963.2013.810232.
 
17.
Dupuis M, Noel-Savina E, Prevot G, et al. Determination of Cardiac Output in Pulmonary Hypertension Using Impedance Cardiography. Respiration. Published online 2018. doi: 10.1159/000486423.
 
18.
Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertens (Dallas, Tex 1979). 2002; 39(5): 982–988. Accessed February 4, 2017. http://www.ncbi.nlm.nih.gov/pu....
 
19.
Siebert J, Gutknecht P, Molisz A, Trzeciak B, Nyka W. Hemodynamic findings in patients with brain stroke. Arch Med Sci. 2012; 8(2). doi: 10.5114/aoms.2012.28567.
 
20.
Krzesiński P, Gielerak G, Kowal J, Piotrowicz K. Usefulness of impedance cardiography in optimisation of antihypertensive treatment in patients with metabolic syndrome: A randomised prospective clinical trial. Kardiol Pol. 2012; 70(6): 599–607.
 
21.
Niklas A, Marcinkowska J, Kozela M, et al. Blood pressure and cholesterol control in patients with hypertension and hypercholesterolemia: The results from the Polish multicenter national health survey WOBASZ II. Polish Arch Intern Med. Published online 2019. doi: 10.20452/pamw.15013.
 
22.
Xiajuan Z, Ding D, Yanyan H, Zhen H. Impedance cardiographic hemodynamic variables and hypertension in elderly Han residents. Ups J Med Sci. 2013; 118(2): 80–86. doi: 10.3109/03009734.2012.756959.
 
23.
Abdelhammed AI, Smith RD, Levy P, Smits GJ, Ferrario CM. Noninvasive hemodynamic profiles in hypertensive subjects. Am J Hypertens. 2005; 18(2 SUPPL.): 51S-59S. doi: 10.1016/j.amjhyper.2004.11.043.
 
24.
Krzesiński P, Gielerak G, Stańczyk A, et al. The effect of hemodynamically-guided hypotensive therapy in one-year observation: Randomized, prospective and controlled trial (FINEPATH study). Cardiol J. 2016; 23(2): 132–140. doi: 10.5603/CJ.a2016.0009.
 
25.
Smith RD, Levy P, Ferrario CM. Value of Noninvasive Hemodynamics to Achieve Blood Pressure Control in Hypertensive Subjects. Hypertension. 2006; 47(4).
 
26.
Fadl Elmula FEM, Hoffmann P, Larstorp AC, et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension. 2014; 63(5): 991–999. doi: 10.1161/HYPERTENSIONAHA.114.03246.
 
eISSN:1898-2263
ISSN:1232-1966